Back to Search
Start Over
Predictive factors for early progression during induction chemotherapy (IC) and chemotherapy-free interval (CFI): Analysis from PRODIGE 9 trial
- Source :
- Annals of oncology (ISSN 0923-7534), The 42nd european society for medical oncology Congress, The 42nd european society for medical oncology Congress, Sep 2017, Madrid, Spain. pp.557P, ⟨10.1093/annonc/mdx393.083⟩, The 42nd european society for medical oncology Congress, Sep 2017, Madrid, Spain. Annals of oncology (ISSN 0923-7534), 28 (suppl_5), pp.557P, 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.083/4109855〉. 〈10.1093/annonc/mdx393.083〉
- Publication Year :
- 2017
- Publisher :
- HAL CCSD, 2017.
-
Abstract
- IF 11.855; International audience
- Subjects :
- Oncology
0303 health sciences
Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Induction chemotherapy
[SDV.CAN]Life Sciences [q-bio]/Cancer
Hematology
3. Good health
Free interval
[ SDV.CAN ] Life Sciences [q-bio]/Cancer
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Predictor variable
business
030304 developmental biology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Annals of oncology (ISSN 0923-7534), The 42nd european society for medical oncology Congress, The 42nd european society for medical oncology Congress, Sep 2017, Madrid, Spain. pp.557P, ⟨10.1093/annonc/mdx393.083⟩, The 42nd european society for medical oncology Congress, Sep 2017, Madrid, Spain. Annals of oncology (ISSN 0923-7534), 28 (suppl_5), pp.557P, 2017, Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8–12 September 2017, Madrid, Spain. 〈https://academic.oup.com/annonc/article/28/suppl_5/mdx393.083/4109855〉. 〈10.1093/annonc/mdx393.083〉
- Accession number :
- edsair.doi.dedup.....70d5fa7e448bead739cd5ca3a1bf8941
- Full Text :
- https://doi.org/10.1093/annonc/mdx393.083⟩